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Performing drug susceptibility tests
Drug susceptibility tests for anaerobes accompany technical
difﬁculties, as compared to similar tests for aerobic bacteria
in general, for the following reasons: (1) special manipu-
lation to avoid contamination by ambient oxygen is needed;
(2) anaerobic culture is needed; (3) the growth rate varies
greatly among different types of anaerobes; and (4) many
anaerobes have high nutritional requirements. Anaerobic
infection more frequently involved in multiple bacterial
infections than the single bacterial form of infection. For
example, 3–5 species of anaerobes are isolated on average
from each case of suppurative anaerobic infection encoun-
tered in the ﬁeld of surgery. At hospital laboratories, a
prevailing view is that unlike the bacterial strains isolated
from blood or cerebrospinal ﬂuid, bacterial strains isolated
from suppurative lesions do not always need to be checked
as to drug susceptibility in a routine manner. Performing
drug susceptibility tests on all such strains is also unfavor-
able from the standpoint of medical economics. However, it
is not uncommon for resistance to various antibacterial
agents to be exhibited by anaerobes isolated from clinical
samples. Furthermore, the trend in resistance of anaerobes
to drugs can change, like the trend in the resistance of
aerobes. Still more, it is not rare for serious outcomes to
manifest if antimicrobial chemotherapy is administered,
ignoring the possible presence of anaerobes, in patients with
major infections known to involve anaerobes.
Under the circumstances described above, it is thought
to be desirable that chemotherapy for suppurative infec-
tions, which account for a high percentage of anaerobic
infections, be based on empirical treatment with antibio-
grams taken into account, and that the therapy be modiﬁed
on the basis of the results of drug susceptibility tests
performed as needed. Clearly, the importance of antibio-
grams during routine clinical practice is higher when per-
forming chemotherapy for anaerobes than for aerobes
because the former does not involve routine drug suscep-
tibility testing. Because antibiograms can vary among
countries, districts or hospitals, it is essential that suscep-
tibility tests be performed periodically on major bacteria
within a country, a district or individual hospital to an
extent practically feasible, to yield information about sus-
ceptibility patterns in a given area. When chemotherapy is
performed on the basis of reported antibiograms, it must be
borne in mind that there may be some differences in sus-
ceptibility patterns or the percentage of resistant strains
among different districts or facilities.
Table 1 lists cases in which susceptibility testing should
be performed on the isolated anaerobes. Table 2 shows
major types of bacteria which require susceptibility tests.
Methods of drug susceptibility tests
Methods available for drug susceptibility evaluation
include the agar dilution, broth microdilution, disc diffu-
sion and cup methods. CLSI (Clinical and Laboratory
Standards Institutes, formerly called NCCLS) [1] recom-
mends the agar dilution and broth microdilution methods
for assessment of the susceptibility of anaerobes to drugs.
The E test is also considered to be useful as an alternative
method. These methods will be outlined below. See rele-
vant references for details of the standard method recom-
mended by the Japanese Society of Chemotherapy, the
CLSI method and E test.
The disc diffusion method, which is recommended for
aerobes, is not recommended for assessment of the
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susceptibility of anaerobes. This simple method is useful
when obtaining reference data, to be used within a given
hospital, on bacterial strains which grow well in about 48 h
in media suitable for their growth. From academic points of
view, however, the data yielded by this test are not for-
mally acceptable as susceptibility data.
Agar dilution method
Agar media, containing drugs in serially twofold diluted
concentrations, are prepared in different dishes. A certain
amount of the test bacterial strain is then inoculated onto
each dish. Inhibition of bacterial growth on the agar
medium is then observed in steps, to determine the mini-
mum concentration allowing the test strain to grow.
This method of susceptibility assessment has undergone
repeated assessments. At present, it is recommended as the
most reliable means of measuring the MIC of drugs against
anaerobes in general. The MIC determined by the agar
dilution method is used as reference information when
assessing the validity of other methods of MIC measure-
ment. This method is used for susceptibility surveillance
and evaluation of new drugs. With this method, the sus-
ceptibility of multiple bacterial strains can be assessed at a
single measurement. However, since it requires diverse
supplies (reagents, devices, etc.) and considerable labor
and time in preparation for the test, this method is not
suitable for susceptibility testing carried out routinely in
laboratories.
The standard method formerly recommended by the
Japanese Society of Chemotherapy [2] conventionally used
modiﬁed GAM agar media, etc., for susceptibility assess-
ment and speciﬁed an amount of bacteria to be inoculated
and the drug concentration unique to Japan (different from
those used in foreign countries) [2]. Recently, however,
this method was revised to update the speciﬁcations given
in the CLSI standard. The revised standard method
[‘‘Standard Agar Dilution Method of the Japanese Society
of Chemotherapy (Revised)’’, reported by the Committee
for Japanese Standards for Antimicrobial Susceptibility
testing for Bacteria at the 52nd General Meeting of the
Japanese Society of Chemotherapy] is separately described
later.
Broth microdilution method
Liquid media, containing drugs in serially twofold diluted
concentrations, are prepared on the wells of a microtiter
plate. A certain amount of the test bacterial strain is
inoculated onto each well. Inhibition of bacterial growth in
each liquid medium is then observed in steps, to determine
the minimum concentration allowing the test strain to
grow.
With this method, susceptibilities of the test strain to
multiple drugs can be assessed using a single microtiter
plate. Manipulations required are simpler with this method
than with agar dilution method. This method is suitable for
routine susceptibility testing, i.e., for assessment of sus-
ceptibility of individual samples brought to the laboratory
in daily practice.
The standard broth microdilution method, recommended
by the Japanese Society of Chemotherapy [3], is the frozen
plate technique by which a microtiter plate carrying liquid
media containing drugs is stored frozen and then subjected
to thawing and preliminary reduction before inoculation
with 1/100 its volume of test bacterial suspension. With
Table 1 Cases in which susceptibility tests should be performed on isolated anaerobes
Strains isolated from blood culture or CSF culture are considered to be clinically signiﬁcant
Strains isolated from cases in which long-term treatment of endocarditis, brain abscess, osteomyelitis, etc., is probably needed
Cases in which anaerobic infection persists and is unresponsive to empiric therapy
Severely ill cases and others in which optimal antibacterial drugs need to be selected, with all isolated strains taken into account (susceptibility
tests should be performed on all isolated strains)
Isolated strains on which few previous reports are available and empirical treatment is difﬁcult
Cases other than those mentioned above in which some strains have been isolated in large amounts from samples collected from usually
aseptic sites
Cases in which the isolated strains seem to exhibit resistance to the drugs usually used for the treatment of anaerobic infections






Fusobacterium nucleatum, F. mortiferum, F. varium
Clostridium perfringens
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Table 3 Drug susceptibility test ‘‘Standard Agar Dilution Method Recommended by the Japanese Society of Chemotherapy (revised)’’
[Target bacteria]
Anaerobes (anaerobes growing well in media designated for use in susceptibility testing)
[Media for susceptibility testing]
Brucella agar medium supplemented with hemin (5 lg/mL), menadione (1 lg/mL) and lysed sheep blood (5%)
[Preparation of bacterial suspension]
hGrowth broth suspension methodi
A thioglycholate medium supplemented with hemin and menadione (containing no indicator agent) is inoculated with a sufﬁcient number of
colonies. Then, incubation is carried out in an incubator until the medium becomes appropriately opaque (for 6–24 h)
hDirect colony suspension methodi
Colonies, incubated for 24–48 h in an appropriate agar medium for anaerobe culture, are directly suspended in a liquid medium for preparing
bacterial suspensions. This step should be completed within 30 min after the anaerobic environment is suspended
hPreparation procedurei
With any of the growth broth suspension method and with the direct colony suspension method, a bacterial suspension with an optical density
level equal to that of the 0.5 McFarland standard solution is prepared, as a rule [Optical density level needs to be adjusted depending on the
type of bacterium. See supplementary provisions in ‘‘the Report by the Committee for Japanese Standards for Antimicrobial Susceptibility
Testing for Bacteria, the Japanese Society of Chemotherapy (1992)’’, vol. 41, p. 183, Journal of the Chemical Society of Japan]. Highly
transparent liquid media (Brucella broth, Anaerobe broth, etc.) should be used as the liquid media for preparing bacterial suspensions. They
need to be reduced or degassed (by boiling and subsequent rapid cooling) before use. Each bacterial suspension should be prepared
immediately before inoculation
[Preparation of antibacterial agents]
hTypes of antibacterial drugsi
Equivalent to those used for facultative bacteria
hDrug dissolving methodi
The drug is prepared at the concentration of serial twofold dilution, including 1 lg/mL in the line of concentration
[Preparation of the agar plate]
hMethodi
1. The medium for susceptibility testing is kept warmed at 48–50C in advance
2. Each antibacterial drug solution is combined with the medium for susceptibility testing at a ratio of 1:9
(1) The agar thickness is 3–4 mm
(2) Agar medium is left standing at room temperature and is thereby induced to solidify. The medium is used immediately after it has
solidiﬁed
hStoragei
As a rule in Japan, the agar plate is used within the same day and is not stored
[Inoculation]
The bacterial suspension is inoculated onto the medium in a volume of 1–2 lL. The ﬁnal density of bacteria inoculated should be 105 cfu/spot.
Because many anaerobes can endure exposure to ambient air if the exposure is brief, all manipulations related to inoculation can be done in
open air. However, depending on the type or strain of bacterium, all manipulations need to be done within an anaerobic glove box
*Precautions
1. At the beginning and end of inoculation of bacterial suspension, two drug-free control media (one for control of anaerobic culture and the
other for control of aerobic culture) are also inoculated with the bacterial suspension to assess the growth of anaerobes and check for
contamination by facultative bacteria
2. Inoculation begins with a plate containing the lowest concentration of the drug and ends with the plate containing the highest concentration
of the drug
3. When the drug type is changed, a drug-free medium is additionally inoculated with the bacterial suspension to conﬁrm the absence of any
inﬂuence from the previous drug
[Culture]
hEnvironmentsi
An anaerobic glove box or one of the containers for anaerobic culture is used
*Precautions
According to the CLSI method, the carbon dioxide concentration should be 4–7% (corresponding to the concentration for the gas pack
method). Bacterial growth is often stimulated as the carbon dioxide concentration rises, but the concentration may not exceed approximately
10%. When reporting the results, the carbon dioxide concentration in the environment should be described
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this technique, the susceptibility of many clinically isolated
anaerobes can be assessed by adequate preliminary
reduction of the media used. Another broth microdilution
method available is the dry plate technique by which the
freeze-dried drug is placed in advance in each well of the
microtiter plate and a certain volume of test bacterial
suspension prepared with the susceptibility assay medium
added to the well before incubation. This technique, which
does not require thawing and preliminary reduction, is
more convenient than the frozen plate technique and is
often used clinical laboratory. However, the dry plate
technique is not identical to the frozen plate technique
recommended as the standard method by the Japanese
Society of Chemotherapy. With the dry plate technique, the
entire inoculated bacterial suspension volume concurrently
serves as the medium for susceptibility assessment. For this
reason, when the liquid medium adjusted to contain a
certain amount of test bacterium is poured into the plate
while exposed to ambient air, the status of preliminary
reduction of the medium differs from that in the medium
used for the frozen plate technique.
When a liquid medium free of blood and other supple-
ments is used for the dry plate technique, there are large
numbers of clinically signiﬁcant bacteria which do not
show growth in this medium, such as black-pigmented
bacteria (Prevotella species, Porphyromonas species),
Fusobacterium species, anaerobic cocci, and so on, unlike
the growth of these types of bacteria in medium used for
the frozen plate technique. If the recently marketed med-
ium (a Brucella broth supplemented with lysed horse
blood, hemin and vitamin K1), recommended by CLSI
(NCCLS M11-A6) as a medium for the broth microdilution
method, is used, even the dry plate technique allows
assessment of the susceptibility of many anaerobic bacteria
including those mentioned above in a generally satisfactory
manner. The dry plate technique is extensively applicable
to routine susceptibility assessment as a substitute for the
frozen plate technique. CLSI (NCCLS M11-A6) does not
refer to the necessity of routine preliminary reduction for
each testing occasion when a frozen plate prepared at a
given facility is used or when a commercial frozen plate or
dry plate is used. However, according to the CLSI rec-
ommendation, the use of this technique is limited to the
B. fragilis group on the grounds that the validity of this
technique has not yet been adequately endorsed for other
bacteria. When broth microdilution is performed using
either a plate prepared at a given facility or a commercial
plate, in any technique (frozen plate or dry plate)
employed, it is essential that the prescribed volume of the
bacterial suspension is followed, that the ﬁnal ﬂuid volume
is equal to 100 lL/well, and that each plate has wells for
growth control.
E test
One side of the plastic strip, used for this method, is coated
with an antibacterial drug in a concentration gradient. The
concentrations used are labeled on the strip surface.
A certain amount of the test bacterial suspension is ino-
culated homogenously onto the agar plate, and this strip is
placed on the agar plate, followed by anaerobic culture. As
a principle, the concentration at the point of crossing
Table 3 continued
hCulture conditionsi
Anaerobic culture is performed for 42–48 h at 35–37C. To conﬁrm the absence of contamination by facultative bacteria, culture under carbon
dioxide should be performed on one of the control media inoculated with the bacterial suspension before the start of anaerobic culture and
another such medium after the start of anaerobic culture
[Reading endpoint]
The concentration (endpoint) is determined macroscopically under adequate illumination, referring to the criteria shown below. *Reference
1. Bacterial growth is markedly suppressed and no bacterial growth is visible at a given concentration
2. Bacterial growth gradually decreases, and only slight growth or a general tendency for haze formation (traces of inoculated bacterial
suspension visible as groups of very small spots) is visible at a given concentration
3. Bacterial growth is markedly suppressed, but many small colonies persist at a given concentration
4. Bacterial growth is markedly suppressed, but several colonies of normal size persist at a given concentration
5. Bacterial growth is markedly suppressed, but haze persists at a given concentration
6. Bacterial growth gradually decreases, and a small number of large colonies are visible at a given concentration
[Quality control]
1. Bacteroides fragilis ATCC25285
2. Bacteroides thetaiotaomicron ATCC29741
3. Eggerthella lenta ATCC43055
Reported by the Committee for Japanese Standards for Antimicrobial Susceptibility testing for Bacteria at the 52nd General Meeting of the
Japanese Society of Chemotherapy
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between the margin of the growth inhibited zone and the
strip indicates the MIC. This strip is a commercially
developed product based on a novel idea. Although CSLI
does not ofﬁcially refer to this product, it has been accepted
as a useful means of susceptibility evaluation. Because this
method uses a medium allowing good growth of the test
strain, it is applicable to assessment of the susceptibility of
a wide range of bacteria, including black-pigmented bac-
teria. It is also reported to be well correlated with agar
dilution method. However, it has been reported that the
validity of this strip is questionable when used on some
types of bacteria and drugs. It is advisable for users of this
strip to obtain information about the types of bacteria or
drugs which require particular care when using this product
from the manufacturer or distributor at the time of pur-
chase. This strip does not require complex manipulations.
It can be used easily even for samples containing a small
number of bacterial strains. Many types of bacteria can be
assessed with this strip. Because of these features, this strip
is convenient for routine susceptibility testing, but it is not
inexpensive.
Quality control
Even when the laboratory staff performs susceptibility
assessment in accordance with a given set of procedures,
the reliability of the test cannot always be assured if there
are problems with the medium, drug, performance of the
plate or manipulation employed. To avoid this type of
problem, it has been recommended that on each occasion
the susceptibility test should include a bacterial strain for
quality control. Bacterial strains recommended for use in
quality control are B. fragilis ATCC25285, B. thetaiota-
omicron ATCC29741 and Eggerthella lenta ATCC43055.
According to the standard susceptibility assessment method
recommended by the Japanese Society of Chemotherapy,
B. fragilis GAI 5524 and B. thetaiotaomicron GAI 5628
can also be used as bacterial strains for quality control. It
has been recommended that 2 or more of the 3 control
strains be used when the agar dilution method is employed
and to use at least one control strain when the broth mic-
rodilution method is employed. The MIC of several indi-
cator drugs against these strains have been presented for
both the agar dilution and the broth microdilution method.
The readings of measurements for these control strains
must be within the acceptable ranges presented. See the
standard method recommended by the Japanese Society of
Chemotherapy [2, 3] and CLSI [1] for details. When sus-
ceptibility is assessed using commercial kits, quality con-
trol should be performed in accordance with the procedure
described in the manufacturer’s instruction (Table 3).
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